GLYCOPEPTIDES AND LINEZOLID MIC CHANGES IN STAPHYLOCOCCUS AUREUS AND COAGULASE NEGATIVE STAPHYLOCOCCI ISOLATES FROM 2008-2011

Yanik K., Yilmaz H., Cayci Y. T., Karadag A., Esen Ş., Gunaydin M.

ACTA MEDICA MEDITERRANEA, cilt.30, sa.5, ss.993-996, 2014 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 5
  • Basım Tarihi: 2014
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.993-996
  • Anahtar Kelimeler: S. aureus, vancomycin, teicoplanin, linezolid, MIC, IN-VITRO SUSCEPTIBILITY, REDUCED SUSCEPTIBILITY, RESISTANT, VANCOMYCIN, BACTEREMIA, HOSPITALS, BLOOD, MRSA
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Aims: Glycopeptides and linezolid are the antimicrobial agents used for the treatment of methicillin resistant Staphylococcus aureus (MRSA) and methicillin resistant Coagulase negative Staphylococci (MRCoNS) infections. It is emerging concern about an increase minimum inhibitor concentration (MIC) of vacomycin among S. aureus strains. In this study, we aimed to analyse the trends in MICs of vancomycin, teicoplanin and linezolid over 4 years (2008-2011) period.